Ticker
HRTXCompany Name
HERON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Invested Capital | Net Income Common Stock | Return on Invested Capital |
---|---|---|---|
6/30/2025 | $ 149.49M | $ -931K | -0.62% |
3/31/2025 | $ 148.8M | $ -7.79M | -5.23% |
12/31/2024 | $ 144.11M | $ -13.58M | -9.42% |
9/30/2024 | $ 138.24M | $ -27.97M | -20.23% |
6/30/2024 | $ 140.77M | $ -48.13M | -34.19% |
3/31/2024 | $ 145.41M | $ -80.95M | -55.67% |
12/31/2023 | $ 145.66M | $ -110.56M | -75.9% |
9/30/2023 | $ 152.21M | $ -119.7M | -78.64% |
6/30/2023 | $ 116.84M | $ -136.6M | -116.91% |
3/31/2023 | $ 145.5M | $ -150.9M | -103.71% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for HERON THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -222.92M ] / Inv. Capital [ $ 301.99M ]
(=) ROIC [ -73.82% ]
Minimum
Jun 30, 2022
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.36K |
---|---|
min | -46.36% |
max | 48.66% |
average | 0.69% |
median | 3.39% |
std | 15.18% |